CoChat
Sign Up
Cited by 143

The DOI matches its Crossref record.

Epidemiology Of Vestibular Schwannomas – Prospective 40-Year Data From An Unselected National Cohort

Reznitsky, Martin, Petersen, Mette Marie Babiel Schmidt, West, Niels, Stangerup, Sven-Eric, Cayé-Thomasen, Per·2019·Clinical Epidemiology
DOI 10.2147/clep.s218670PMC PMC6850685
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/clep.s218670

Cites

Statistics

Figures

Figure 1 Annual number of diagnosed vestibular schwannomas in Denmark during the 40-year period 1976–2015. The Danish population was 5.1 million in 1976 and 5.7 million in 2015.
Figure 1 Annual number of diagnosed vestibular schwannomas in Denmark during the 40-year period 1976–2015. The Danish population was 5.1 million in 1976 and 5.7 million in 2015.CC BY-NC · PubMed Central
Figure 2 Mean tumor size at diagnosis over the 40-year period 1976–2015.
Figure 2 Mean tumor size at diagnosis over the 40-year period 1976–2015.CC BY-NC · PubMed Central
Figure 3 Proportions of different tumor size groups (in mm) over the 40-year period 1976–2015.
Figure 3 Proportions of different tumor size groups (in mm) over the 40-year period 1976–2015.CC BY-NC · PubMed Central
Figure 4 Median patient age at diagnosis over the 40-year period 1976–2015.
Figure 4 Median patient age at diagnosis over the 40-year period 1976–2015.CC BY-NC · PubMed Central
Figure 5 Proportions of different age groups over the 40-year period 1976–2015.
Figure 5 Proportions of different age groups over the 40-year period 1976–2015.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 41

  1. [1]Stangerup S-E, Tos M, Caye-Thomasen P, Tos T, Klokker M, Thomsen J. Increasing annual incidence of vestibular schwannoma and age at diagnosis. J Laryngol Otol. 2004; 118(8): 622– 627. doi: 10.1258/0022215041917989 15453938 · DOI
  2. [2]Thomsen J, Tos M, Harmsen A, Riishede J, Thornval G. Surgery of acoustic neuromas. Preliminary experience with a translabyrinthine approach. Acta Neurol Scand. 1977; 56(4): 277– 290. 920109
  3. [3]Tos M, Thomsen J. Epidemiology of acoustic neuromas. J Laryngol Otol. 1984; 98(7): 685– 692. doi: 10.1017/s0022215100147292 6747450 · DOI
  4. [4]Tos M, Thomsen J, Charabi S. Incidence of acoustic neuromas. Ear Nose Throat J. 1992; 71(9): 391– 393. 1425377
  5. [5]Tos M, Charabi S, Thomsen J. Incidence of vestibular schwannomas. Laryngoscope. 1999; 109(5): 736– 740. doi: 10.1097/00005537-199905000-00011 10334223 · DOI
  6. [6]Stangerup S-E, Tos M, Thomsen J, Caye-Thomasen P. True incidence of vestibular schwannoma? Neurosurgery. 2010; 67(5): 1335– 1340. discussion 1340. doi: 10.1227/NEU.0b013e3181f22660 20871439 · DOI
  7. [7]Stangerup S-E, Caye-Thomasen P. Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin North Am. 2012; 45(2): 257– 268, vii. doi: 10.1016/j.otc.2011.12.008 22483814 · DOI
  8. [8]Nestor JJ, Korol HW, Nutik SL, Smith R. The incidence of acoustic neuromas. Arch Otolaryngol Head Neck Surg. 1988; 114(6): 680. doi: 10.1001/archotol.1988.01860180094042 3365341 · DOI
  9. [9]Frohlich AM, Sutherland GR. Epidemiology and clinical features of vestibular schwannoma in Manitoba, Canada. Can J Neurol Sci. 1993; 20(2): 126– 130. doi: 10.1017/s0317167100047685 8334574 · DOI
  10. [10]Evans DGR, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R. Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol. 2005; 26(1): 93– 97. 15699726
  11. [11]Mirz F, Pedersen CB, Fiirgaard B, Lundorf E. Incidence and growth pattern of vestibular schwannomas in a Danish county, 1977–98. Acta Otolaryngol Suppl. 2000; 543: 30– 33. doi: 10.1080/000164800453883 10908969 · DOI
  12. [12]Carlson ML, Habermann EB, Wagie AE, et al. The changing landscape of vestibular schwannoma management in the United Statesâ—a shift toward conservatism. Otolaryngol Head Neck Surg. 2015; 153(3): 440– 446. doi: 10.1177/0194599815590105 26129740 · DOI
  13. [13]Kshettry VR, Hsieh JK, Ostrom QT, Kruchko C, Barnholtz-Sloan JS. Incidence of vestibular schwannomas in the United States. J Neurooncol. 2015; 124(2): 223– 228. doi: 10.1007/s11060-015-1827-9 26024654 · DOI
  14. [14]Propp JM, McCarthy BJ, Davis FG, Preston-Martin S. Descriptive epidemiology of vestibular schwannomas. Neuro-Oncology. 2006; 8(1): 1– 11. doi: 10.1215/S1522851704001097 16443943 PMC1871924 · DOI
  15. [15]Kleijwegt M, Ho V, Visser O, Godefroy W, van der Mey A. Real incidence of vestibular schwannoma? Estimations from a national registry. Otol Neurotol. 2016; 37(9): 1411– 1417. doi: 10.1097/MAO.0000000000001169 27525713 · DOI
  16. [16]Koo M, Lai J-T, Yang EY-L, Liu T-C, Hwang J-H. Incidence of vestibular schwannoma in taiwan from 2001 to 2012: a population-based national health insurance study. Ann Otol Rhinol Laryngol. 2018; 127(10): 694– 697. doi: 10.1177/0003489418788385 30032646 · DOI
  17. [17]Marinelli JP, Lohse CM, Carlson ML. Incidence of vestibular schwannoma over the past half-century: a population-based study of Olmsted County, Minnesota. Otolaryngol Head Neck Surg. 2018; 159(4): 717– 723. doi: 10.1177/0194599818770629 29712512 PMC6339687 · DOI
  18. [18]Kanzaki J, Tos M, Sanna M, Moffat DA, Monsell EM, Berliner KI. New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma. Otol Neurotol. 2003; 24(4): 642– 648. discussion 648–649. 12851559
  19. [19]Schwartz M, Fisher L. Incidence and clinical characteristics of acoustic neuroma in beverly hills. Skull Base. 2006; 16(S 1): A040. doi: 10.1055/s-2006-958307 · DOI
  20. [20]Stepanidis K, Kessel M, Caye-Thomasen P, Stangerup S-E. Socio-demographic distribution of vestibular schwannomas in Denmark. Acta Otolaryngol. 2014; 134(6): 551– 556. doi: 10.3109/00016489.2014.890293 24655069 · DOI
  21. [21]Sass HCR, Borup R, Alanin M, Nielsen FC, Cayé-Thomasen P. Gene expression, signal transduction pathways and functional networks associated with growth of sporadic vestibular schwannomas. J Neurooncol. 2017; 131(2): 283– 292. doi: 10.1007/s11060-016-2292-9 27752882 · DOI
  22. [22]Burkhart CG. Herpes and acoustic neuromas: is there a cause and effect to observe? Med Hypotheses. 2010; 74(6): 1013– 1014. doi: 10.1016/j.mehy.2010.01.010 20153934 · DOI
  23. [23]Bhimrao SK, Maguire J, Garnis C, et al. Lack of association between human herpesvirus and vestibular schwannoma: analysis of 121 cases. Otolaryngol Head Neck Surg. 2015; 152(3): 513– 517. doi: 10.1177/0194599814563517 25560404 · DOI
  24. [24]Corona AP, Ferrite S, da Silva Lopes M, Rêgo MAV. Risk factors associated with vestibular nerve schwannomas. Otol Neurotol. 2012; 33(3): 459– 465. doi: 10.1097/MAO.0b013e3182487fee 22377646 · DOI
  25. [25]Berkowitz O, Iyer AK, Kano H, Talbott EO, Lunsford LD. Epidemiology and environmental risk factors associated with vestibular schwannoma. World Neurosurg. 2015; 84(6): 1674– 1680. doi: 10.1016/j.wneu.2015.07.007 26171891 · DOI
  26. [26]Dilwali S, Kao S-Y, Fujita T, Landegger LD, Stankovic KM. Nonsteroidal anti-inflammatory medications are cytostatic against human vestibular schwannomas. Transl Res. 2015; 166(1): 1– 11. doi: 10.1016/j.trsl.2014.12.007 25616959 PMC4458444 · DOI
  27. [27]Kandathil CK, Cunnane ME, McKenna MJ, Curtin HD, Stankovic KM. Correlation between aspirin intake and reduced growth of human vestibular schwannoma: volumetric analysis. Otol Neurotol. 2016; 37(9): 1428– 1434. doi: 10.1097/MAO.0000000000001180 27631829 · DOI
  28. [28]Hunter JB, O’Connell BP, Wanna GB, et al. Vestibular schwannoma growth with aspirin and other nonsteroidal anti-inflammatory drugs. Otol Neurotol. 2017; 38(8): 1158– 1164. doi: 10.1097/MAO.0000000000001506 28692590 · DOI
  29. [29]Marinelli JP, Lees KA, Tombers NM, Lohse CM, Carlson ML. Impact of aspirin and other NSAID use on volumetric and linear growth in vestibular schwannoma. Otolaryngol Head Neck Surg. 2019; 160(6): 194599819827812. doi: 10.1177/0194599819827812 30717626 · DOI
  30. [30]Schoemaker MJ, Swerdlow AJ, Auvinen A, et al. Medical history, cigarette smoking and risk of acoustic neuroma: an international case-control study. Int J Cancer. 2007; 120(1): 103– 110. doi: 10.1002/ijc.22272 17019705 · DOI
  31. [31]Benson VS, Green J, Pirie K, Beral V. Cigarette smoking and risk of acoustic neuromas and pituitary tumours in the million women study. Br J Cancer. 2010; 102(11): 1654– 1656. doi: 10.1038/sj.bjc.6605695 20461083 PMC2883161 · DOI
  32. [32]Palmisano S, Schwartzbaum J, Prochazka M, et al. Role of tobacco use in the etiology of acoustic neuroma. Am J Epidemiol. 2012; 175(12): 1243– 1251. doi: 10.1093/aje/kwr465 22517809 PMC3372315 · DOI
  33. [33]Chen M, Fan Z, Zheng X, Cao F, Wang L. Risk factors of acoustic neuroma: systematic review and meta-analysis. Yonsei Med J. 2016; 57(3): 776– 783. doi: 10.3349/ymj.2016.57.3.776 26996581 PMC4800371 · DOI
  34. [34]Prochazka M, Feychting M, Ahlbom A, et al. Occupational exposures and risk of acoustic neuroma. Occup Environ Med. 2010; 67(11): 766– 771. doi: 10.1136/oem.2009.047886 20581419 · DOI
  35. [35]Schuz J, Steding-Jessen M, Hansen S, et al. Long-term mobile phone use and the risk of vestibular schwannoma: a Danish nationwide cohort study. Am J Epidemiol. 2011; 174(4): 416– 422. doi: 10.1093/aje/kwr112 21712479 · DOI
  36. [36]Fisher JL, Pettersson D, Palmisano S, et al. Loud noise exposure and acoustic neuroma. Am J Epidemiol. 2014; 180(1): 58– 67. doi: 10.1093/aje/kwu081 24786799 · DOI
  37. [37]Roswall N, Stangerup S-E, Cayé-Thomasen P, et al. Residential traffic noise exposure and vestibular schwannomaâ-a Danish case-control study. Acta Oncol. 2017; 56(10): 1310– 1316. doi: 10.1080/0284186X.2017.1337925 28609173 · DOI
  38. [38]Ron E, Modan B, Boice JD, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med. 1988; 319(16): 1033– 1039. doi: 10.1056/NEJM198810203191601 3173432 · DOI
  39. [39]Preston DL, Ron E, Yonehara S, et al. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst. 2002; 94(20): 1555– 1563. doi: 10.1093/jnci/94.20.1555 12381708 · DOI
  40. [40]Evans DGR, Birch JM, Ramsden RT, Sharif S, Baser ME. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. J Med Genet. 2006; 43(4): 289– 294. doi: 10.1136/jmg.2005.036319 16155191 PMC2563223 · DOI
  41. [41]Pollock BE, Link MJ, Stafford SL, Parney IF, Garces YI, Foote RL. The risk of radiation-induced tumors or malignant transformation after single-fraction intracranial radiosurgery: results based on a 25-year experience. Int J Radiat Oncol Biol Phys. 2017; 97(5): 919– 923. doi: 10.1016/j.ijrobp.2017.01.004 28333013 · DOI

Cited by

Sorted by citations

See all 143

Metadata

Authors
Reznitsky, M., Petersen, M. M. B. S., West, N., Stangerup, S.-E., & Cayé-Thomasen, P.
ORCID
Venue
Clinical Epidemiology
Publisher
Informa UK Limited
Published
2019-11
Volume
Volume 11
Pages
981-986
ISSN
1179-1349
DOI
10.2147/clep.s218670
PMC
PMC6850685
Cited by
143
References
0
Language
en
Licence
creativecommons.org/licenses/by-nc/3.0/ (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidemiology Of Vestibular Schwannomas – Prospective 40-Year Data From An Unselected National Cohort. https://app.cochat.ai/papers/10.2147/clep.s218670
The paper
Reznitsky, M., Petersen, M. M. B. S., West, N., Stangerup, S.-E., & Cayé-Thomasen, P. (2019). Epidemiology Of Vestibular Schwannomas – Prospective 40-Year Data From An Unselected National Cohort. Clinical Epidemiology. https://doi.org/10.2147/clep.s218670